正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

For the 1st time, a randomized controlled clinical trial has demonstrated that an intensive lifestyle intervention, without drugs, may significantly improve cognition & function in many patients with mild cognitive impairment or early dementia due to Alzheimer’s disease.

Dean Ornish, MD

50,485 subscribers

12,832 次观看 • 2 年前 •via X (Twitter)

教育健康养生科学技术

Anya Rossi• Live Now

Private livecam show

5 条评论

Daniel Wilson 的头像

Daniel Wilson2 年前

Wonderful. What measurements or metrics did you use to determine improvement in cognition? MCA or other?

Garry Lee 的头像

Garry Lee2 年前

It would be astonishing if it didn't work.

Susan Masterson, Ph.D. 的头像

Susan Masterson, Ph.D.2 年前

Do you have any data about how long the subjects were able to sustain the lifestyle changes after the study ended?

Jesse Levey 的头像

Jesse Levey2 年前

How do you offer a randomized trial more love?

Martin S. Matko 的头像

Martin S. Matko2 年前

DYK Apparantly.... So happens the original terminology 'Liberation Treatmenti' is that of #BloodFlowMatters FB Group: MultipleStenosisSociety! @ms_matko If your veins are blocked they should be opened if you have SymptoMS or not!

相关视频

Supplementing vitamin D could significantly boost memory and attention—even in people already facing cognitive decline Clinical trials found that adults with mild cognitive impairment or Alzheimer’s improved cognition after one year of taking just 800 IU/day vitamin D Patients with Alzheimer’s also saw reduced blood markers linked to disease progression (amyloid-beta 42)

Supplementing vitamin D could significantly boost memory and attention—even in people already facing cognitive decline Clinical trials found that adults with mild cognitive impairment or Alzheimer’s improved cognition after one year of taking just 800 IU/day vitamin D Patients with Alzheimer’s also saw reduced blood markers linked to disease progression (amyloid-beta 42)

FoundMyFitness Clips

14,130 次观看 • 1 年前

🚨BREAKING NEWS🚨 The U.S. FDA has granted Eisai an accelerated licence for #lecanemab in people with a confirmed diagnosis of mild cognitive impairment or early-stage Alzheimer’s in the US. Head of Policy, David Thomas, explains more 👇

🚨BREAKING NEWS🚨 The U.S. FDA has granted Eisai an accelerated licence for #lecanemab in people with a confirmed diagnosis of mild cognitive impairment or early-stage Alzheimer’s in the US. Head of Policy, David Thomas, explains more 👇

Alzheimer's Research UK

76,276 次观看 • 3 年前

Supplementing with creatine (20 grams/day) improved cognitive function in Alzheimer’s patients by nearly 5% after just 8 weeks Patients experienced notable gains in memory, fluid cognition, inhibitory control, and attention (likely due to creatine’s key role in brain energy metabolism) Creatine seems to especially benefit the brain under stress (whether Alzheimer's, sleep deprivation, or depression), making it a promising tool for supporting cognitive health

Supplementing with creatine (20 grams/day) improved cognitive function in Alzheimer’s patients by nearly 5% after just 8 weeks Patients experienced notable gains in memory, fluid cognition, inhibitory control, and attention (likely due to creatine’s key role in brain energy metabolism) Creatine seems to especially benefit the brain under stress (whether Alzheimer's, sleep deprivation, or depression), making it a promising tool for supporting cognitive health

FoundMyFitness Clips

114,013 次观看 • 9 个月前

90% of people aren’t getting enough choline, and it’s quietly driving up their risk for heart disease and dementia Even slight deficiencies in choline can elevate homocysteine levels—a biomarker strongly linked to cardiovascular disease and cognitive decline Choline is also vital for brain function and development In fact, a randomized controlled trial found that pregnant women who increased their daily choline intake from roughly 500 milligrams (the recommended amount) to about 900 milligrams had children who scored dramatically higher on IQ and cognitive function tests Fortunately, eating around ~3 eggs per day or supplementing with phosphatidylcholine can correct this deficiency

90% of people aren’t getting enough choline, and it’s quietly driving up their risk for heart disease and dementia Even slight deficiencies in choline can elevate homocysteine levels—a biomarker strongly linked to cardiovascular disease and cognitive decline Choline is also vital for brain function and development In fact, a randomized controlled trial found that pregnant women who increased their daily choline intake from roughly 500 milligrams (the recommended amount) to about 900 milligrams had children who scored dramatically higher on IQ and cognitive function tests Fortunately, eating around ~3 eggs per day or supplementing with phosphatidylcholine can correct this deficiency

FoundMyFitness Clips

39,362 次观看 • 1 年前

BREAKING: A new pilot clinical study just tested an intriguing Alzheimer’s idea: instead of targeting amyloid or tau, what if we target biological aging itself? They tested Senolytics, drugs that clear senescent cells. These drugs just showed they can improve cognition AND mobility in older adults at risk for Alzheimer's. This is the first human trial of its kind. Here's what happened 🧵

BREAKING: A new pilot clinical study just tested an intriguing Alzheimer’s idea: instead of targeting amyloid or tau, what if we target biological aging itself? They tested Senolytics, drugs that clear senescent cells. These drugs just showed they can improve cognition AND mobility in older adults at risk for Alzheimer's. This is the first human trial of its kind. Here's what happened 🧵

Harshi Peiris, Ph.D.

21,290 次观看 • 4 个月前

Brain Breakthrough: Metabolizing Alzheimer’s 🧠Alzheimer's disease is a metabolic disease where brain cells, including neurons and their support cells called astrocytes, struggle to produce energy ⚡️This energetic failure contributes to dementia. New research has identified a key protein in brain metabolism, IDO1, that contributes to energy crisis in Alzheimer’s disease In brief: 👉The amyloid and tau pathologies of Alzhimer’s disease can converge to increase IDO1 activity in astrocytes 👉This leads to impairment in the ability of astrocytes to make lactate as a source of energy for neurons 👉This ultimately leads to neuronal metabolic failure in Alzheimer’s disease and other dementias 🧠Impressively, inhibition of IDO1 with an existing cancer drug can rescue the Alzheimer’s brain in three independent mouse models, with parallel findings in human cells taken from patients with Alzheimer’s disease #AlzheimersDisease #BrainHealth #MetabolicHealth

Brain Breakthrough: Metabolizing Alzheimer’s 🧠Alzheimer's disease is a metabolic disease where brain cells, including neurons and their support cells called astrocytes, struggle to produce energy ⚡️This energetic failure contributes to dementia. New research has identified a key protein in brain metabolism, IDO1, that contributes to energy crisis in Alzheimer’s disease In brief: 👉The amyloid and tau pathologies of Alzhimer’s disease can converge to increase IDO1 activity in astrocytes 👉This leads to impairment in the ability of astrocytes to make lactate as a source of energy for neurons 👉This ultimately leads to neuronal metabolic failure in Alzheimer’s disease and other dementias 🧠Impressively, inhibition of IDO1 with an existing cancer drug can rescue the Alzheimer’s brain in three independent mouse models, with parallel findings in human cells taken from patients with Alzheimer’s disease #AlzheimersDisease #BrainHealth #MetabolicHealth

Nick Norwitz

41,959 次观看 • 1 年前

For the first time, a study suggests that Alzheimer's disease may be preventable if treatment begins early, before symptoms appear. CBS News' Jonathan LaPook, M.D spoke with the doctor leading the clinical trial.

For the first time, a study suggests that Alzheimer's disease may be preventable if treatment begins early, before symptoms appear. CBS News' Jonathan LaPook, M.D spoke with the doctor leading the clinical trial.

CBS Evening News with Tony Dokoupil

21,183 次观看 • 7 个月前

U.S. citizens are traveling to Havana for a new breakthrough treatment for Alzheimer’s disease. Clinical trials show that, unlike any other medication, Cuba’s NeuralCIM not only stabilizes patients, but in more than half of cases it actually reverses many Alzheimer’s symptoms.

U.S. citizens are traveling to Havana for a new breakthrough treatment for Alzheimer’s disease. Clinical trials show that, unlike any other medication, Cuba’s NeuralCIM not only stabilizes patients, but in more than half of cases it actually reverses many Alzheimer’s symptoms.

Belly of the Beast

325,189 次观看 • 4 个月前

An experimental gene therapy from UniQuire reduced disease progression in Huntington's patients by 75% over 36 months in a clinical trial, marking a significant milestone for the rare inherited brain disorder that has no FDA-approved treatments

An experimental gene therapy from UniQuire reduced disease progression in Huntington's patients by 75% over 36 months in a clinical trial, marking a significant milestone for the rare inherited brain disorder that has no FDA-approved treatments

Reuters

53,077 次观看 • 9 个月前

Pregnant women who supplement with choline may have smarter babies A randomized controlled trial found that mothers who nearly doubled their daily choline intake (from about ~480 mg to ~930 mg) had children who scored dramatically higher on IQ and cognitive function tests Choline is vital for brain function and development, and egg yolks are one of the richest dietary sources

Pregnant women who supplement with choline may have smarter babies A randomized controlled trial found that mothers who nearly doubled their daily choline intake (from about ~480 mg to ~930 mg) had children who scored dramatically higher on IQ and cognitive function tests Choline is vital for brain function and development, and egg yolks are one of the richest dietary sources

FoundMyFitness Clips

99,316 次观看 • 9 个月前

Vitamin D supplementation was associated with a 40% lower risk of dementia over a decade. After five years, 84% of supplement users were dementia-free compared to just 68% of non-users in a study of over 12,000 people. Vitamin D reduced dementia risk by 33% in adults with mild cognitive impairment or APOE e4, a key genetic risk factor for neurodegenerative diseases. Vitamin D isn’t just a vitamin—it's a steroid hormone regulating over 2,000 genes critical for brain development, neuroplasticity, and inflammation control. Its roles include clearing amyloid beta plaques and tau buildup, boosting neuron survival via neurotrophic factors like BDNF, and enhancing brain connectivity, particularly when paired with exercise. It’s no surprise, then, that higher vitamin D levels are associated with better cognition, larger hippocampal volume, and lower Alzheimer’s risk. Multiple lines of evidence support this. More than 30 large studies have consistently linked low vitamin D levels to a 50–150% increased dementia risk. People genetically prone to low vitamin D—those with genetic variations affecting vitamin D production or metabolism—have a 54% higher dementia risk. Furthermore, supplementing with 800 IU/day of vitamin D improves memory and cognitive function in people with mild cognitive impairment and more serious forms of dementia. To learn more about optimizing vitamin D levels for cognitive health, including underlying brain-protective mechanisms and practical supplementation protocols, see the latest FoundMyFitness video. Link in comments.

Vitamin D supplementation was associated with a 40% lower risk of dementia over a decade. After five years, 84% of supplement users were dementia-free compared to just 68% of non-users in a study of over 12,000 people. Vitamin D reduced dementia risk by 33% in adults with mild cognitive impairment or APOE e4, a key genetic risk factor for neurodegenerative diseases. Vitamin D isn’t just a vitamin—it's a steroid hormone regulating over 2,000 genes critical for brain development, neuroplasticity, and inflammation control. Its roles include clearing amyloid beta plaques and tau buildup, boosting neuron survival via neurotrophic factors like BDNF, and enhancing brain connectivity, particularly when paired with exercise. It’s no surprise, then, that higher vitamin D levels are associated with better cognition, larger hippocampal volume, and lower Alzheimer’s risk. Multiple lines of evidence support this. More than 30 large studies have consistently linked low vitamin D levels to a 50–150% increased dementia risk. People genetically prone to low vitamin D—those with genetic variations affecting vitamin D production or metabolism—have a 54% higher dementia risk. Furthermore, supplementing with 800 IU/day of vitamin D improves memory and cognitive function in people with mild cognitive impairment and more serious forms of dementia. To learn more about optimizing vitamin D levels for cognitive health, including underlying brain-protective mechanisms and practical supplementation protocols, see the latest FoundMyFitness video. Link in comments.

Dr. Rhonda Patrick

245,165 次观看 • 1 年前

Gupta: He keeps citing this constant passing of the Montreal Cognitive Assessment test… This is not a tool that the general public should be utilizing with that level of frequency unless there’s a reason to do it—which is to assess and monitor the evolution of mild dementia or impairment.

Gupta: He keeps citing this constant passing of the Montreal Cognitive Assessment test… This is not a tool that the general public should be utilizing with that level of frequency unless there’s a reason to do it—which is to assess and monitor the evolution of mild dementia or impairment.

Acyn

68,029 次观看 • 6 个月前

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:

NEJM

12,209 次观看 • 3 个月前

For the first time, ultrasound is being used to try and slow down the cognitive decline of Alzheimer’s disease.

For the first time, ultrasound is being used to try and slow down the cognitive decline of Alzheimer’s disease.

60 Minutes

75,038 次观看 • 2 年前

Supplementing with vitamin D could cut your risk of dementia by nearly half In a study of more than 12,000 older adults, those who supplemented with vitamin D were 40% less likely to develop dementia over the following decade And after just 5 years, 84% of vitamin D users remained dementia-free compared to only 68% of non-users This benefit even extended to people with mild cognitive impairment and the APOE4 gene—a major genetic risk factor for Alzheimer's disease

Supplementing with vitamin D could cut your risk of dementia by nearly half In a study of more than 12,000 older adults, those who supplemented with vitamin D were 40% less likely to develop dementia over the following decade And after just 5 years, 84% of vitamin D users remained dementia-free compared to only 68% of non-users This benefit even extended to people with mild cognitive impairment and the APOE4 gene—a major genetic risk factor for Alzheimer's disease

FoundMyFitness Clips

273,514 次观看 • 1 年前

She shares a few simple exercises to prevent alzheimer’s disease/dementia:

She shares a few simple exercises to prevent alzheimer’s disease/dementia:

Art of Life 🦋

231,506 次观看 • 4 个月前

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵

JAMA

13,166 次观看 • 2 个月前

“There hasn’t been a single randomized clinical trial that has demonstrated any benefit for young people with this (COVID mRNA) jab” -Joseph A. Ladapo, MD, PhD It’s wild to see the medical establishment still pushing this when the evidence clearly shows there’s no benefit… Good to hear that HHS is considering removing the COVID vax recommendation for children and pregnant women. The facts don't wait—it's past time to act!

“There hasn’t been a single randomized clinical trial that has demonstrated any benefit for young people with this (COVID mRNA) jab” -Joseph A. Ladapo, MD, PhD It’s wild to see the medical establishment still pushing this when the evidence clearly shows there’s no benefit… Good to hear that HHS is considering removing the COVID vax recommendation for children and pregnant women. The facts don't wait—it's past time to act!

Casey DeSantis

28,076 次观看 • 1 年前

Dementia & Alzheimer’s Disease in Kashmir – Explained | Doctor's Mic | Ep 8 In an in depth conversation on today's episode of Doctor's Mic, Dr Zubair Saleem, Greater Kashmir's Health Editor speaks with renowned neurologist Prof Parvaiz Ahmad Shah about the rising concern of dementia and Alzheimer’s disease in Kashmir #dementiaawareness #alzeimersawareness #kashmir

Dementia & Alzheimer’s Disease in Kashmir – Explained | Doctor's Mic | Ep 8 In an in depth conversation on today's episode of Doctor's Mic, Dr Zubair Saleem, Greater Kashmir's Health Editor speaks with renowned neurologist Prof Parvaiz Ahmad Shah about the rising concern of dementia and Alzheimer’s disease in Kashmir #dementiaawareness #alzeimersawareness #kashmir

Greater Kashmir

17,153 次观看 • 4 个月前

What is the difference between Alzheimer’s disease and dementia.

What is the difference between Alzheimer’s disease and dementia.

Life Science

40,540 次观看 • 5 个月前